Select Page

Review of Medicines and Medical Device Regulation in Australia

The Australian Government is undertaking an independent review of the regulatory arrangements for medicines and medical devices. RANZCO’s primary concerns in response to the Expert Panel’s discussion paper relate to patient safety; timely patient access to medicines; stable supply to reduce the advent of drug shortages; appropriate red tape for use of unapproved products; and incentives for sponsors to register medicines for niche ophthalmic indications.

RANZCO’s submission is available here.

Last updated: November 9, 2018

Get in Touch

Do you have any queries or comments about our website, our products or any  of our services?
RANZCO acknowledges our First Australians, the Traditional Custodians of the land
on which we live and work, and pays respect to Elders past, present and emerging.
Gadigal people of the Eora Nation are the traditional custodians of the land
where the RANZCO head office is located.
In recognition that we are a bi-national College, we also
acknowledge the Rangatiratanga of Māori as Tangata Whenua
and Treaty of Waitangi partners in Aotearoa New Zealand.